SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000818686-08-000071
Filing Date
2008-04-10
Accepted
2008-04-10 11:37:13
Documents
3
Period of Report
2008-04-10

Document Format Files

Seq Description Document Type Size
1 COPAXONE? SIGNIFICANTLY REDUCED ANNUAL RELAPSE RATES AND STABILIZED DISEASE PROG copaxone100408.htm 6-K 72172
3 LOGO image001.jpg GRAPHIC 3735
4 COPAXONE? SIGNIFICANTLY REDUCED ANNUAL RELAPSE RATES AND STABILIZED DISEASE PROG copaxone100408.pdf 6-K 281949
  Complete submission text file 0000818686-08-000071.txt   467700
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 08749238
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1